Should Travellers have Priorities for COVID 19 Vaccine?
Najim Z. Alshahrani, Sultan M. Alshahrani, Nada Fussi, Mohammed J. Alsheef
Journal of Pharmaceutical Research International · pp. 38–40 · Published 6 Feb 2021
10.9734/jpri/2020/v32i4731111Abstract
The “Type of Article” of this paper is “Letter to the Editor”. This paper discuses about: “Should Travellers have Priorities for COVID 19 Vaccine?”. No formal abstract is available. Readers are requested to read the full article.
Cited by 1
Ahmed D Alharbi, A. Alharbi · Journal of Pharmaceutical Research International · 2022
Related research
- COVID 19 Disease Caused by Coronavirus 2 (SARS-CoV-2) (Severe Acute Respiratory Syndrome) — shares topic coverage
- Assessment of Anxiety in Healthcare Providers Working in ICU during COVID-19 Pandemics — shares topic coverage
- Azithromycin and Hydroxychloroquine Accelerate Recovery of Outpatients with Mild/Moderate COVID-19 — shares topic coverage
- Elevated Levels of Lactate Dehydrogenase Predicts Poor Outcomes for Patients with COVID-19: A Review — shares topic coverage
- Addressing the Challenges of Containing Covid-19 Spread in a Rural, Poor Area in India: A Case Study — shares topic coverage
Article metrics
Real usage data collected on this platform.
0
Page views
0
PDF downloads
0
Outbound clicks
1
Citations
Views by country
Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".
No views recorded yet.
Traffic sources
Referring site, by host.
No traffic recorded yet.
Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.